Betulinic Acid Modulates the Expression of HSPA and Activates Apoptosis in Two Cell Lines of Human Colorectal Cancer

Betulinic acid (BA) is a pentacyclic triterpene usually isolated from botanical sources. Numerous studies have reported the inhibitory effect of BA against human colorectal cancer cells (CRC). However, its effect on the expression of the molecular chaperone HSPA is unclear. The aim of this research...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laphatrada Yurasakpong, Chanin Nantasenamat, Saksit Nobsathian, Kulathida Chaithirayanon, Somjai Apisawetakan
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/07e16231d1ac4ba6ab4c85dcfb65dfa2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:07e16231d1ac4ba6ab4c85dcfb65dfa2
record_format dspace
spelling oai:doaj.org-article:07e16231d1ac4ba6ab4c85dcfb65dfa22021-11-11T18:24:22ZBetulinic Acid Modulates the Expression of HSPA and Activates Apoptosis in Two Cell Lines of Human Colorectal Cancer10.3390/molecules262163771420-3049https://doaj.org/article/07e16231d1ac4ba6ab4c85dcfb65dfa22021-10-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6377https://doaj.org/toc/1420-3049Betulinic acid (BA) is a pentacyclic triterpene usually isolated from botanical sources. Numerous studies have reported the inhibitory effect of BA against human colorectal cancer cells (CRC). However, its effect on the expression of the molecular chaperone HSPA is unclear. The aim of this research is to investigate the anti-cancer activities of BA purified from <i>Piper retrofractum</i> and study its effect on the expression of HSPA in colorectal cancer HCT116 and SW480 cells. The viability of both cancer cells was reduced after they were treated with an increasing dosage of BA. Flow cytometry assay revealed that levels of cell apoptosis significantly increased after incubation with BA in both cancer cells. Pro-apoptotic markers including Bax, cleaved-caspase-3 and cleaved-caspase-9 were increased while anti-apoptotic marker Bcl-2 was decreased after BA treatment. Western blot also showed that the expression of HSPA fluctuated upon BA treatment, whereby HSPA was increased at lower BA concentrations while at higher BA concentrations HSPA expression was decreased. Preliminary molecular docking assay showed that BA can bind to the nucleotide binding domain of the HSP70 at its ADP-bound state of the HSP70. Although further research is needed to comprehend the BA-HSPA interaction, our findings indicate that BA can be considered as potential candidate for the development of new treatment for colorectal cancer.Laphatrada YurasakpongChanin NantasenamatSaksit NobsathianKulathida ChaithirayanonSomjai ApisawetakanMDPI AGarticlebetulinic acidHSPAapoptosiscolorectal cancerOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6377, p 6377 (2021)
institution DOAJ
collection DOAJ
language EN
topic betulinic acid
HSPA
apoptosis
colorectal cancer
Organic chemistry
QD241-441
spellingShingle betulinic acid
HSPA
apoptosis
colorectal cancer
Organic chemistry
QD241-441
Laphatrada Yurasakpong
Chanin Nantasenamat
Saksit Nobsathian
Kulathida Chaithirayanon
Somjai Apisawetakan
Betulinic Acid Modulates the Expression of HSPA and Activates Apoptosis in Two Cell Lines of Human Colorectal Cancer
description Betulinic acid (BA) is a pentacyclic triterpene usually isolated from botanical sources. Numerous studies have reported the inhibitory effect of BA against human colorectal cancer cells (CRC). However, its effect on the expression of the molecular chaperone HSPA is unclear. The aim of this research is to investigate the anti-cancer activities of BA purified from <i>Piper retrofractum</i> and study its effect on the expression of HSPA in colorectal cancer HCT116 and SW480 cells. The viability of both cancer cells was reduced after they were treated with an increasing dosage of BA. Flow cytometry assay revealed that levels of cell apoptosis significantly increased after incubation with BA in both cancer cells. Pro-apoptotic markers including Bax, cleaved-caspase-3 and cleaved-caspase-9 were increased while anti-apoptotic marker Bcl-2 was decreased after BA treatment. Western blot also showed that the expression of HSPA fluctuated upon BA treatment, whereby HSPA was increased at lower BA concentrations while at higher BA concentrations HSPA expression was decreased. Preliminary molecular docking assay showed that BA can bind to the nucleotide binding domain of the HSP70 at its ADP-bound state of the HSP70. Although further research is needed to comprehend the BA-HSPA interaction, our findings indicate that BA can be considered as potential candidate for the development of new treatment for colorectal cancer.
format article
author Laphatrada Yurasakpong
Chanin Nantasenamat
Saksit Nobsathian
Kulathida Chaithirayanon
Somjai Apisawetakan
author_facet Laphatrada Yurasakpong
Chanin Nantasenamat
Saksit Nobsathian
Kulathida Chaithirayanon
Somjai Apisawetakan
author_sort Laphatrada Yurasakpong
title Betulinic Acid Modulates the Expression of HSPA and Activates Apoptosis in Two Cell Lines of Human Colorectal Cancer
title_short Betulinic Acid Modulates the Expression of HSPA and Activates Apoptosis in Two Cell Lines of Human Colorectal Cancer
title_full Betulinic Acid Modulates the Expression of HSPA and Activates Apoptosis in Two Cell Lines of Human Colorectal Cancer
title_fullStr Betulinic Acid Modulates the Expression of HSPA and Activates Apoptosis in Two Cell Lines of Human Colorectal Cancer
title_full_unstemmed Betulinic Acid Modulates the Expression of HSPA and Activates Apoptosis in Two Cell Lines of Human Colorectal Cancer
title_sort betulinic acid modulates the expression of hspa and activates apoptosis in two cell lines of human colorectal cancer
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/07e16231d1ac4ba6ab4c85dcfb65dfa2
work_keys_str_mv AT laphatradayurasakpong betulinicacidmodulatestheexpressionofhspaandactivatesapoptosisintwocelllinesofhumancolorectalcancer
AT chaninnantasenamat betulinicacidmodulatestheexpressionofhspaandactivatesapoptosisintwocelllinesofhumancolorectalcancer
AT saksitnobsathian betulinicacidmodulatestheexpressionofhspaandactivatesapoptosisintwocelllinesofhumancolorectalcancer
AT kulathidachaithirayanon betulinicacidmodulatestheexpressionofhspaandactivatesapoptosisintwocelllinesofhumancolorectalcancer
AT somjaiapisawetakan betulinicacidmodulatestheexpressionofhspaandactivatesapoptosisintwocelllinesofhumancolorectalcancer
_version_ 1718431803688091648